Send to

Choose Destination
Urol Res. 1992;20(2):117-20.

An immunohistological demonstration of c-erbB-2 oncoprotein expression in primary urothelial bladder cancer.

Author information

Department of Surgery, University of Queensland, Herston, Australia.


Sections of formalin-fixed, paraffin-blocked tissue from 116 primary transitional cell carcinomas were stained immunohistochemically using a polyclonal antibody against the c-erbB-2 oncoprotein. Positive staining of cell membranes, known to correlate with gene amplification, was seen in 22 (19%) of the 116, with variable staining from tumour to tumour and within tumours themselves. Consistent with its mooted value as a prognosticator in bladder cancer, the c-erbB-2 oncoprotein was detected in 13 (of 40) grade III and 9 of the 26 muscle-invasive tumours examined compared to 1 (of 25) grade I and 6 (of 66) mucosa only (pTa) lesions. These results support further examination of c-erbB-2 expression in bladder cancer.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center